Johnson and Johnson, together with Takeda and OrbiMed have launched FutuRx in Rehovot’s Weizmann Science Park.  Its first start-up is Hepy Biosciences, which is developing a tumor enzyme inhibitor. The second, XoNovo, is developing a treatment that targets a protein implicated in Alzheimer’s.

http://www.timesofisrael.com/jj-takeda-team-up-to-open-israeli-biotech-incubator/